Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 131Colonic Neoplasms 72Rectal Neoplasms 61Breast Neoplasms 61Stomach Neoplasms 37Pancreatic Neoplasms 31Squamous Cell Carcinoma of Head and Neck 27Esophageal Neoplasms 24Head and Neck Neoplasms 23Neoplasm Metastasis 22Esophageal Squamous Cell Carcinoma 16Carcinoma, Hepatocellular 16Adenocarcinoma Of Esophagus 16Parkinson Disease 4, Autosomal Dominant Lewy Body 14Neoplasms 11Nasopharyngeal Carcinoma 11Adenocarcinoma 7Urinary Bladder Neoplasms 5Keratosis, Actinic 5Cholangiocarcinoma 5Anus Neoplasms 5Intestinal Neoplasms 4Inflammatory Breast Neoplasms 4Hepatoblastoma 4Gastrointestinal Neoplasms 4Digestive System Neoplasms 4Biliary Tract Neoplasms 4Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3HIV Infections 3

Interventions

Oxaliplatin 2Leucovorin 2Irinotecan 2Fluorouracil 2Bevacizumab 2Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Adenocarcinoma × Fluorouracil × Clear all
NCT06951503 2026-03-04

AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

Akeso

Phase 3 Recruiting
560 enrolled
Gastrointestinal

Colorectal Adenocarcinoma

NCT04094688 2026-03-03

SOLARIS

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
455 enrolled 13 charts
Gastrointestinal

Colorectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡